Anika Therapeutics (ANIK) FCF Margin (2010 - 2026)
Anika Therapeutics (ANIK) posted quarterly FCF Margin of 6.54% for Q2 2026, down 67.0% year-over-year from 19.82% in Q2 2025, and up 69.14% quarter-over-quarter from 21.2% in Q1 2026.
Anika Therapeutics (ANIK) FCF Margin (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has reported FCF Margin for 17 consecutive years, with 6.54% the latest figure, recorded in Q2 2026.
- In Q2 2026, FCF Margin fell 67.0% year-over-year to 6.54%; the TTM figure through Jun 2026 stood at 0.47% (up 93.0% YoY), while the FY2025 annual figure was 3.87%, up 581.0% from the prior year.
- FCF Margin grew to 6.54% in Q2 2026 per ANIK's latest filing, from 21.2% in the prior quarter.
- Across five years, FCF Margin topped out at 73.48% in Q4 2022 and bottomed at 62.02% in Q4 2023.
- Historically, FCF Margin has averaged 1.92% across 5 years, with a median of 6.2% in 2025.
- Annual changes were most pronounced in 2022 — FCF Margin soared 6415 bps — and 2023, when it plunged 13551 bps.
- Anika Therapeutics' FCF Margin stood at 73.48% in 2022, then plunged by 184 bps to 62.02% in 2023, then soared by 101 bps to 0.9% in 2024, then soared by 1350 bps to 13.03% in 2025, then plunged by 150 bps to 6.54% in 2026.
- Business Quant data shows ANIK's FCF Margin at 6.54% in Q2 2026, 21.2% in Q1 2026, and 13.03% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 7.41% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 21.80% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 14.87% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 26.25% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 8.76% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 13.41% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 17.84% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Anika Therapeutics | 284.33 Mn | 245.92 Mn | 21.24 Mn | -6.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.54% |
| Mar 31, 2026 | -21.20% |
| Dec 31, 2025 | 13.03% |
| Sep 30, 2025 | 17.91% |
| Jun 30, 2025 | -5.87% |
| Mar 31, 2025 | -11.29% |
| Dec 31, 2024 | 0.90% |
| Sep 30, 2024 | 12.86% |
| Jun 30, 2024 | -14.56% |
| Mar 31, 2024 | -6.66% |
| Dec 31, 2023 | -62.02% |
| Sep 30, 2023 | 13.85% |
| Jun 30, 2023 | -22.01% |
| Mar 31, 2023 | -13.20% |
| Dec 31, 2022 | 73.48% |
| Sep 30, 2022 | 2.53% |
| Jun 30, 2022 | 2.89% |
| Mar 31, 2022 | -8.71% |
| Dec 31, 2021 | 9.34% |
| Sep 30, 2021 | 1.97% |